Abstract:Type 1 diabetes (T1D) is an autoimmune disease in which immune-mediated targeting and destruction of insulin-producing pancreatic islet β cells leads to chronic hyperglycemia. There are many β cell proteins that are targeted by autoreactive T cells in their native state. However, recent studies have demonstrated that many β cell proteins are recognized as neo-antigens following posttranslational modification (PTM). Although modified neo-antigens are well-established targets of pathology in other autoimmune diseases, the effects of neo-antigens in T1D progression and the mechanisms by which they are generated are not well understood. We have demonstrated that PTM occurs during endoplasmic reticulum (ER) stress, a process to which β cells are uniquely susceptible due to the high rate of insulin production in response to dynamic glucose sensing. In the context of genetic susceptibility to autoimmunity, presentation of these modified neo-antigens may activate autoreactive T cells and cause pathology. However, inherent β cell ER stress and protein PTM do not cause T1D in every genetically susceptible individual, suggesting the contribution of additional factors. Indeed, many environmental factors, such as viral infection, chemicals, or inflammatory cytokines, are associated with T1D onset, but the mechanisms by which these factors lead to disease onset remain unknown. Since these environmental factors also cause ER stress, exposure to these factors may enhance production of neo-antigens, therefore boosting β cell recognition by autoreactive T cells and exacerbating T1D pathogenesis. Therefore, the combined effects of physiological ER stress and the stress that is induced by environmental factors may lead to breaks in peripheral tolerance, contribute to antigen spread, and hasten disease onset. This Hypothesis and Theory article summarizes what is currently known about ER stress and protein PTM in autoimmune diseases including T1D and proposes a role for environmental factors in breaking immune tolerance to β cell antigens through neo-antigen formation.

β cell ER stress and the implications for immunogenicity in type 1 diabetes

Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?

Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis

Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Extracellular vesicles derived from stressed beta cells mediate monocyte activation and contribute to islet inflammation

Setting the Stage for Islet Autoimmunity in Type 2 Diabetes: Obesity-Associated Chronic Systemic Inflammation and Endoplasmic Reticulum (ER) Stress

ER stress and the decline and fall of pancreatic beta cells in type 1 diabetes

Inside the β Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

Immunopeptidome mining reveals a novel ERS-induced target in T1D

Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response

Endoplasmic reticulum stress in pancreatic β-cell dysfunctionality and diabetes mellitus: a promising target for generation of functional hPSC-derived β-cells in vitro

The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes

Disrupted Endoplasmic Reticulum Ca2+ Handling: A Harβinger of β-Cell Failure

Cross Talk between β Cells and Immune Cells: What We Know, What We Think We Know, and What We Should Learn

Innate Immunity in Type 1 Diabetes